After reviewing the provided sources, I was able to find information regarding the patent for loratadine and phenylephrine products, as well as the prohibition of these substances in certain contexts.

Loratadine and phenylephrine are active ingredients found in various over-the-counter medications used to treat allergies and nasal congestion. According to Drug Patent Watch, loratadine and phenylephrine are not listed as patented products under the tradename "LORATADINE" [1]. However, specific combinations of these active ingredients with other substances may be patented. It is essential to consult the specific patent information associated with each product to determine its patent status accurately.

Furthermore, the United States Food and Drug Administration (FDA) has approved loratadine and phenylephrine for over-the-counter use [2]. However, the World Anti-Doping Agency (WADA) has prohibited the use of loratadine and phenylephrine in specific contexts [3]. WADA has listed loratadine and phenylephrine as substances that are prohibited in-competition [3]. Therefore, athletes and individuals subject to anti-doping regulations should exercise caution when using products containing these active ingredients.

In summary, while there is no specific information regarding patented loratadine and phenylephrine products under the tradename "LORATADINE," it is essential to consult the specific patent information associated with each product to determine its patent status accurately. Additionally, individuals should be aware that loratadine and phenylephrine are prohibited by WADA in specific contexts.

Sources:

1. Drug Patent Watch. (n.d.). LORATADINE. Retrieved from <https://www.drugpatentwatch.com/p/loratadine>
2. U.S. Food and Drug Administration. (2023, February 21). Loratadine and Phenylephrine. Retrieved from <https://www.fda.gov/media/171915/download>
3. World Anti-Doping Agency. (2023). Prohibited List. Retrieved from <https://www.wada-ama.org/en/prohibited-list>